Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Abstract
The BCL-2 protein family determines the commitment of cells to apoptosis, an ancient cell suicide programme that is essential for development, tissue homeostasis and immunity. Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischaemic conditions and drive neurodegeneration. We discuss the biochemical, structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold. These mechanistic insights into the functions of the BCL-2 family are illuminating the physiological control of apoptosis, the pathological consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Together with BOK, BCL2 family apoptosis regulator (BOK) [47], BAX and BAK are the only BCL2 family members characterized so far in mammalian cells for their ability to form pores across the outer mitochondrial membrane (OMM) and possibly other intracellular membranes [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“which is controlled by pro-apoptotic and anti-apoptotic members of the BCL2, apoptosis regulator (BCL2) protein family, a group of proteins sharing one to four BCL2 homology (BH) domains (i.e., BH1, BH2, BH3, and BH4) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Intrinsic apoptosis is a form of RCD initiated by a variety of microenvironmental perturbations including (but not limited to) growth factor withdrawal, DNA damage, endoplasmic reticulum (ER) stress, reactive oxygen species (ROS) overload, replication stress, microtubular alterations or mitotic defects [29–34].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“MOMP is antagonized by anti-apoptotic members of the BCL2 family, including BCL2 itself, BCL2 like 1 (BCL2L1; best known as BCL-XL), MCL1, BCL2 family apoptosis regulator (MCL1), BCL2 like 2 (BCL2L2; best known as BCL-W), and BCL2 related protein A1 (BCL2A1; best known—in human—as BFL-1) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Thus, most pro-survival BCL2 family members inhibit BAX and BAK by preventing their oligomerization and pore-forming activity either directly, upon physical sequestration at the OMM, or indirectly, following the sequestration of BH3-only activators [29, 64, 79, 110].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679
Self-citationThe landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Self-citation
Cited by
Items 101–200 of 1,008
Obexer, P., & Ausserlechner, M. J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00197 · Cited by 244
Alzheimer’s Disease: From Firing Instability to Homeostasis Network Collapse
Frere, S., & Slutsky, I. (2018) · Neuron · doi:10.1016/j.neuron.2017.11.028 · Cited by 237
Ceramides bind VDAC2 to trigger mitochondrial apoptosis
Dadsena, S., Bockelmann, S., Mina, J. G. M., Hassan, D. G., Korneev, S., Razzera, G., Jahn, H., Niekamp, P., Müller, D., Schneider, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09654-4 · Cited by 234
Fogarty, C. E., & Bergmann, A. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.47 · Cited by 235
Liu, J., Liu, W., Lu, Y., Tian, H., Duan, C., Lu, L., Gao, G., Wu, X., Wang, X., & Yang, H. (2018) · Autophagy · doi:10.1080/15548627.2017.1390636 · Cited by 231
The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation
Birkinshaw, R. W., & Czabotar, P. E. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.04.001 · Cited by 229
Self-citationStructural Model of Active Bax at the Membrane
Bleicken, S., Jeschke, G., Stegmueller, C., Salvador-Gallego, R., García-Sáez, A. J., & Bordignon, E. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.022 · Cited by 227
“The model proposed here retains the idea of a core and latch domain in active Bax and Bak (Brouwer et al., 2014; Czabotar et al., 2013, 2014), but describes the relative arrangement of the helices in the full-length oligomeric Bax at the membrane.”
Sarosiek, K. A., Fraser, C., Muthalagu, N., Bhola, P. D., Chang, W., McBrayer, S. K., Cantlon, A., Fisch, S., Golomb-Mello, G., Ryan, J. A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.11.011 · Cited by 226
Wright, D. J., Day, F. R., Kerrison, N. D., Zink, F., Cardona, A., Sulem, P., Thompson, D. J., Sigurjonsdottir, S., Gudbjartsson, D. F., Helgason, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3821 · Cited by 224
BCL-2 as therapeutic target for hematological malignancies
Perini, G. F., Ribeiro, G. N., Pinto Neto, J. V., Campos, L. T., & Hamerschlak, N. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0608-2 · Cited by 223
Deo, P., Chow, S. H., Han, M.-L., Speir, M., Huang, C., Schittenhelm, R. B., Dhital, S., Emery, J., Li, J., Kile, B. T., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0773-2 · Cited by 221
Targeting the Mitotic Catastrophe Signaling Pathway in Cancer
Mc Gee, M. M. (2015) · Mediators of Inflammation · doi:10.1155/2015/146282 · Cited by 221
“The family is comprised of multidomain prosurvival proteins (Bcl-2, Bcl-XL, Bcl-W, Mcl1, A1, and Bcl-B) and multidomain proapoptotic effector proteins (Bax, Bak, and Bok) as well as BH3-only proteins (Bim, PUMA, Bad, NOXA, Bik, Hrk, Bmf, and tBid) [74].”
Um, H.-D. (2016) · Oncotarget · doi:10.18632/oncotarget.6405 · Cited by 219
“Bcl-2 family proteins are key regulators of cell death that can either suppress or promote apoptosis [1-3].”
BackgroundAkl, H., Vervloessem, T., Kiviluoto, S., Bittremieux, M., Parys, J. B., De Smedt, H., & Bultynck, G. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.04.017 · Cited by 215
Autophagy as a modulator of cell death machinery
Noguchi, M., Hirata, N., Tanaka, T., Suizu, F., Nakajima, H., & Chiorini, J. A. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2724-5 · Cited by 214
Targeting MCL-1 in hematologic malignancies: Rationale and progress
Wei, A. H., Roberts, A. W., Spencer, A., Rosenberg, A. S., Siegel, D., Walter, R. B., Caenepeel, S., Hughes, P., McIver, Z., Mezzi, K., et al. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100672 · Cited by 210
“If the surge in BH3-only protein activity exceeds the inhibitory capacity of prevailing prosurvival BCL-2 family members, the effector proteins BAX and BAK may be activated, resulting in outer mitochondrial membrane permeabilization and release of activators of the caspase cascade (Figure 1) [1, 2].”
BackgroundInfluentialThe p53/p21 Complex Regulates Cancer Cell Invasion and Apoptosis by Targeting Bcl-2 Family Proteins
Kim, E. M., Jung, C.-H., Kim, J., Hwang, S.-G., Park, J. K., & Um, H.-D. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2098 · Cited by 211
“Upon apoptotic stimulation, p53 translocates from the cell nucleus to the mitochondria where it interacts with Bcl-2 family proteins to regulate apoptosis (4, 5).”
BackgroundLiu, H., Liu, S., Qiu, X., Yang, X., Bao, L., Pu, F., Liu, X., Li, C., Xuan, K., Zhou, J., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1717128 · Cited by 209
“Apoptosis, a form of programmed cell death, is an important biological process and plays a critical role in development, tissue homeostasis, and immunity [15].”
BackgroundInhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
Akçay, G., Belmonte, M. A., Aquila, B., Chuaqui, C., Hird, A. W., Lamb, M. L., Rawlins, P. B., Su, N., Tentarelli, S., Grimster, N. P., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2174 · Cited by 207
Discoveries and controversies in BCL‐2 protein‐mediated apoptosis
Zheng, J. H., Viacava Follis, A., Kriwacki, R. W., & Moldoveanu, T. (2016) · The FEBS Journal · doi:10.1111/febs.13527 · Cited by 207
Embryogenesis and Adult Life in the Absence of Intrinsic Apoptosis Effectors BAX, BAK, and BOK
Ke, F. F. S., Vanyai, H. K., Cowan, A. D., Delbridge, A. R. D., Whitehead, L., Grabow, S., Czabotar, P. E., Voss, A. K., & Strasser, A. (2018) · Cell · doi:10.1016/j.cell.2018.04.036 · Cited by 205
Self-citationInside job: Staphylococcus aureus host-pathogen interactions
Horn, J., Stelzner, K., Rudel, T., & Fraunholz, M. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.11.009 · Cited by 206
LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis
Li, J., Zhang, M., An, G., & Ma, Q. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370215622708 · Cited by 205
Shi, L., Hu, F., Duan, Y., Wu, W., Dong, J., Meng, X., Zhu, X., & Liu, B. (2020) · ACS Nano · doi:10.1021/acsnano.9b09032 · Cited by 203
VDAC2 enables BAX to mediate apoptosis and limit tumor development
Chin, H. S., Li, M. X., Tan, I. K. L., Ninnis, R. L., Reljic, B., Scicluna, K., Dagley, L. F., Sandow, J. J., Kelly, G. L., Samson, A. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07309-4 · Cited by 196
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
Maeda, Y., Nishikawa, H., Sugiyama, D., Ha, D., Hamaguchi, M., Saito, T., Nishioka, M., Wing, J. B., Adeegbe, D., Katayama, I., et al. (2014) · Science · doi:10.1126/science.aaa1292 · Cited by 200
Strategies targeting cellular senescence
Ovadya, Y., & Krizhanovsky, V. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95149 · Cited by 200
“Antiapoptotic proteins of the BCL-2 protein family are well studied on the molecular level and are potentially attractive drug targets (50).”
BackgroundCell Death and Inflammation: The Role of Mitochondria in Health and Disease
Picca, A., Calvani, R., Coelho-Junior, H. J., & Marzetti, E. (2021) · Cells · doi:10.3390/cells10030537 · Cited by 198
“Here, they serve anti-apoptotic functions by binding and blocking pro-apoptotic proteins of the BCL2 family [104,105].”
BackgroundThe Involvement of Mg2+ in Regulation of Cellular and Mitochondrial Functions
Pilchova, I., Klacanova, K., Tatarkova, Z., Kaplan, P., & Racay, P. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6797460 · Cited by 198
Potential mechanisms of resistance to venetoclax and strategies to circumvent it
Tahir, S. K., Smith, M. L., Hessler, P., Rapp, L. R., Idler, K. B., Park, C. H., Leverson, J. D., & Lam, L. T. (2017) · BMC Cancer · doi:10.1186/s12885-017-3383-5 · Cited by 195
Multiple roles of caspase-8 in cell death, inflammation, and innate immunity
Orning, P., & Lien, E. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0420-305r · Cited by 197
Homocysteine and Mitochondria in Cardiovascular and Cerebrovascular Systems
Kaplan, P., Tatarkova, Z., Sivonova, M. K., Racay, P., & Lehotsky, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207698 · Cited by 196
“The activation results in binding of BH3 domain-only proteins to anti-apoptotic proteins followed by Bax and/or Bak activation and consequent initiation of mitochondrial apoptosis [99].”
BackgroundSenescent Cells: Emerging Targets for Human Aging and Age-Related Diseases
Song, S., Lam, E. W.-F., Tchkonia, T., Kirkland, J. L., & Sun, Y. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.03.008 · Cited by 195
“Antiapoptotic proteins of the Bcl-2 family are well investigated as potentially exploitable drug targets [91] and they play multiple roles in cell death modulation via regulation of apoptosis and autophagy [92].”
BackgroundBax and Bak Pores: Are We Closing the Circle?
Cosentino, K., & García-Sáez, A. J. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.004 · Cited by 190
“Thus, controlling apoptosis represents an important therapeutic target for the treatment of related diseases [2,3].”
BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells
Maes, M. E., Schlamp, C. L., & Nickells, R. W. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.01.002 · Cited by 191
“Modified from (Czabotar et al., 2014).”
Five-Membered Ring Peroxide Selectively Initiates Ferroptosis in Cancer Cells
Abrams, R. P., Carroll, W. L., & Woerpel, K. A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00900 · Cited by 187
“mitochondrial pathway of apoptosis.(4,5) The BCL2 gene was identified as one of six genes that”
Ma, H., Luo, J., Sun, Z., Xia, L., Shi, M., Liu, M., Chang, J., & Wu, C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.005 · Cited by 189
STAT3 and apoptosis challenges in cancer
Fathi, N., Rashidi, G., Khodadadi, A., Shahi, S., & Sharifi, S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.121 · Cited by 187
Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics
Wijdeven, R. H., Pang, B., Assaraf, Y. G., & Neefjes, J. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.07.001 · Cited by 187
Han, J.-Y., Li, Q., Ma, Z.-Z., & Fan, J.-Y. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.005 · Cited by 184
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
Lee, E. F., Harris, T. J., Tran, S., Evangelista, M., Arulananda, S., John, T., Ramnac, C., Hobbs, C., Zhu, H., Gunasingh, G., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1568-3 · Cited by 185
Self-citationThe essentials of developmental apoptosis
Voss, A. K., & Strasser, A. (2020) · F1000Research · doi:10.12688/f1000research.21571.1 · Cited by 183
“(4) The role of a number of BCL-2 family members in development remains to be determined, while single knockout of the genes encoding these does not result in overt phenotypic anomalies, which is possibly due to functional redundancies.”
BackgroundSelf-citationProgress in understanding the role of lncRNA in programmed cell death
Jiang, N., Zhang, X., Gu, X., Li, X., & Shang, L. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00407-1 · Cited by 182
Diverse functions of cytochrome c in cell death and disease
Zhou, Z., Arroum, T., Luo, X., Kang, R., Lee, Y. J., Tang, D., Hüttemann, M., & Song, X. (2024) · Cell Death & Differentiation · doi:10.1038/s41418-024-01284-8 · Cited by 176
“Some BH3-only proteins, such as truncated Bid (tBid) and Bim, may also directly bind and activate Bax and Bak [13, 110, 124], although such interaction appears to be dispensable for Bax/Bak-mediated apoptosis [125, 126].”
Mcl-1 Ubiquitination: Unique Regulation of an Essential Survival Protein
Mojsa, B., Lassot, I., & Desagher, S. (2014) · Cells · doi:10.3390/cells3020418 · Cited by 181
“According to the unified model that is being widely accepted [4,5,35], Mcl-1 blocks MOMP by inactivating the pro-apoptotic proteins Bak and Bax.”
BackgroundBAX, BAK, and BOK: A Coming of Age for the BCL-2 Family Effector Proteins
Moldoveanu, T., & Czabotar, P. E. (2020) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036319 · Cited by 181
“…for BAK and BAX is relatively low (KD ∼ µM), structural analysis by NMR and X-ray crystallography has lagged behind that of the much tighter complexes occurring between BH3 peptides and antiapoptotic BCL-2 proteins (KD∼ nM) (Suzuki et al. 2000; Moldoveanu et al. 2006, 2013; Czabotar et al. 2013).”
BackgroundSelf-citationSubburaj, Y., Cosentino, K., Axmann, M., Pedrueza-Villalmanzo, E., Hermann, E., Bleicken, S., Spatz, J., & García-Sáez, A. J. (2015) · Nature Communications · doi:10.1038/ncomms9042 · Cited by 181
Mitochondrial alterations in apoptosis
Cosentino, K., & García-Sáez, A. J. (2014) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2014.04.001 · Cited by 181
Redox controls UPR to control redox
Eletto, D., Chevet, E., Argon, Y., & Appenzeller-Herzog, C. (2014) · Journal of Cell Science · doi:10.1242/jcs.153643 · Cited by 180
“JNK also stimulates BIM and represses BCL2 through phosphorylation, which provides a further link to mitochondrial dysfunction (Lei and Davis, 2003; Putcha et al., 2003; Yamamoto et al., 1999).”
BackgroundInfluentialThe MYCN Protein in Health and Disease
Ruiz-Pérez, M. V., Henley, A. B., & Arsenian-Henriksson, M. (2017) · Genes · doi:10.3390/genes8040113 · Cited by 181
Apoptosis in Cancer Biology and Therapy
Moyer, A., Tanaka, K., & Cheng, E. H. (2025) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-115023 · Cited by 173
Mohammad, I., Starskaia, I., Nagy, T., Guo, J., Yatkin, E., Väänänen, K., Watford, W. T., & Chen, Z. (2018) · Science Signaling · doi:10.1126/scisignal.aap9415 · Cited by 173
“B cell lymphoma 2 (Bcl2) is decreased by T cell activation and is a prosurvival protein that maintains lymphocyte survival (34, 35).”
BackgroundVenetoclax for AML: changing the treatment paradigm
Pollyea, D. A., Amaya, M., Strati, P., & Konopleva, M. Y. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000937 · Cited by 174
“The BCL-2 family proteins’ roles can be divided into 4 main functions: suppressors (BCL-2, BCL-XL, BCL-W, BCL2-A1, and MCL-1), activators (BIM and PUMA), effectors (BAX and BAK), and sensitizers (NOXA).(8,9) Suppressors inhibit the activity of activators and effectors, preventing apoptosis, whereas sensitizers inhibit…”
BackgroundThe molecular relationships between apoptosis, autophagy and necroptosis
Lalaoui, N., Lindqvist, L. M., Sandow, J. J., & Ekert, P. G. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.02.003 · Cited by 175
“The generation f homo-oligomers of BAX or BAK forms structures that permebilize the outer mitochondrial membrane leading to a number f irreversible outcomes for the cell [11].”
BackgroundMetabolic Regulation of Apoptosis in Cancer
(2016) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2016.06.006 · Cited by 177
PUMA amplifies necroptosis signaling by activating cytosolic DNA sensors
Chen, D., Tong, J., Yang, L., Wei, L., Stolz, D. B., Yu, J., Zhang, J., & Zhang, L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717190115 · Cited by 177
“Bcl-2 family proteins are evolutionarily conserved cell death regulators that include prosurvival members, such as Bcl-2 and Bcl-XL, and the proapoptotic members Bax/Bak and BH3-only proteins (10).”
BackgroundCastillo, R. R., Colilla, M., & Vallet-Regí, M. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1211637 · Cited by 176
“which the most representative is Bcl-2 (B-Cell Lymphoma 2) [41,42] or heat-shock proteins (HSP) [43], whose overexpression prevents cellular death.”
BackgroundTargeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
Inoue-Yamauchi, A., Jeng, P. S., Kim, K., Chen, H.-C., Han, S., Ganesan, Y. T., Ishizawa, K., Jebiwott, S., Dong, Y., Pietanza, M. C., et al. (2017) · Nature Communications · doi:10.1038/ncomms16078 · Cited by 173
Cassim, S., Vučetić, M., Ždralević, M., & Pouyssegur, J. (2020) · Cancers · doi:10.3390/cancers12051119 · Cited by 175
Zhang, L., Zhang, L., Li, L., & Hölscher, C. (2019) · Journal of Parkinson's Disease · doi:10.3233/jpd-181503 · Cited by 173
Horiuchi, D., Camarda, R., Zhou, A. Y., Yau, C., Momcilovic, O., Balakrishnan, S., Corella, A. N., Eyob, H., Kessenbrock, K., Lawson, D. A., et al. (2016) · Nature Medicine · doi:10.1038/nm.4213 · Cited by 170
Basu, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107943 · Cited by 171
PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
Zhao, Y., Wang, W., Guo, S., Wang, Y., Miao, L., Xiong, Y., & Huang, L. (2016) · Nature Communications · doi:10.1038/ncomms11822 · Cited by 171
PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment
Gao, J., Xiong, A., Liu, J., Li, X., Wang, J., Zhang, L., Liu, Y., Xiong, Y., Li, G., & He, X. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00765-9 · Cited by 170
Control of cell death and mitochondrial fission by ERK 1/2 MAP kinase signalling
Cook, S. J., Stuart, K., Gilley, R., & Sale, M. J. (2017) · The FEBS Journal · doi:10.1111/febs.14122 · Cited by 170
Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance
Shahar, N., & Larisch, S. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100712 · Cited by 165
Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity
Ma, W., Wei, S., Zhang, B., & Li, W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00434 · Cited by 168
The Bcl-2 family: structures, interactions and targets for drug discovery
Kvansakul, M., & Hinds, M. G. (2015) · Apoptosis · doi:10.1007/s10495-014-1051-7 · Cited by 168
“Frequently, dysregulation of the Bcl-2 family is an important, though not the only, mechanism by which such malignant transformations occur [18] and recognized in many cancers [19, 20].”
BackgroundThe Developing Story of Predictive Biomarkers in Colorectal Cancer
Boussios, S., Ozturk, M., Moschetta, M., Karathanasi, A., Zakynthinakis-Kyriakou, N., Katsanos, K., Christodoulou, D., & Pavlidis, N. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9010012 · Cited by 168
“Additional mechanisms include apoptosis, drug metabolism, DNA damage repair dysfunctions and dysregulation of cell cycle checkpoints [12].”
BackgroundLi, K., Deng, Y., Deng, G., Chen, P., Wang, Y., Wu, H., Ji, Z., Yao, Z., Zhang, X., Yu, B., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01643-5 · Cited by 167
“xL, and proapoptotic proteins, such as BAX, are the most important regulators of apoptosis processes [23].”
BackgroundTanaka, K., Yu, H. A., Yang, S., Han, S., Selcuklu, S. D., Kim, K., Ramani, S., Ganesan, Y. T., Moyer, A., Sinha, S., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.07.006 · Cited by 163
Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment
Correia, C., Lee, S.-H., Meng, X. W., Vincelette, N. D., Knorr, K. L. B., Ding, H., Nowakowski, G. S., Dai, H., & Kaufmann, S. H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.03.012 · Cited by 166
“Since the discovery of Bcl-2 [17,93,94] and its ability to promote tumorigenesis by inhibiting cell death [95], five structurally related antiapoptotic family members, including Bcl-xL, Mcl-1, Bcl-w, BFL1 (A1 in mouse) and Bcl-B (Bcl2L10 in mouse), have been identified [10,11,96].”
InfluentialLi, C., Zhang, G., Zhao, L., Ma, Z., & Chen, H. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0769-9 · Cited by 167
“Bcl-2 family proteins have long been recognized as crucial mediators of mitochondrial apoptotic signaling, also referred to as intrinsic apoptosis [44, 45].”
MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis
Shirjang, S., Mansoori, B., Asghari, S., Duijf, P. H. G., Mohammadi, A., Gjerstorff, M., & Baradaran, B. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.017 · Cited by 167
Lycorine: A prospective natural lead for anticancer drug discovery
Roy, M., Liang, L., Xiao, X., Feng, P., Ye, M., & Liu, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.147 · Cited by 164
“The death receptor-mediated (or extrinsic) pathway of apoptosis is activated when certain death receptor ligands of the tumor necrosis factor (TNF) family (such as FAS ligand and TNF) engage their cognate death receptors (FAS and TNFR1, respectively) on the plasma membrane, leading to caspase-8 activation [77] [78] [7…”
Zhang, Y., Zhang, H., Zhao, F., Jiang, Z., Cui, Y., Ou, M., Mei, L., & Wang, Q. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.06.011 · Cited by 160
“As a central player in the regulation of apoptosis, the BCL-2 protein family could regulate apoptosis by the control of mitochondrial permeability 4,38,39 .”
BackgroundCombating subclonal evolution of resistant cancer phenotypes
Brady, S. W., McQuerry, J. A., Qiao, Y., Piccolo, S. R., Shrestha, G., Jenkins, D. F., Layer, R. M., Pedersen, B. S., Miller, R. H., Esch, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01174-3 · Cited by 163
Role of mitochondrial dysfunction and oxidative stress in sensorineural hearing loss
Tan, W. J. T., & Song, L. (2023) · Hearing Research · doi:10.1016/j.heares.2023.108783 · Cited by 159
Brouwer, J. M., Westphal, D., Dewson, G., Robin, A. Y., Uren, R. T., Bartolo, R., Thompson, G. V., Colman, P. M., Kluck, R. M., & Czabotar, P. E. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.07.016 · Cited by 161
“Increasing our understanding of the mechanisms underlying cell death may provide novel avenues for therapeutic development similar to recent advances with antagonists of prosurvival proteins (Czabotar et al., 2014).”
BackgroundSelf-citationEischen, C. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026096 · Cited by 161
Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer
Merino, D., Lok, S. W., Visvader, J. E., & Lindeman, G. J. (2016) · Oncogene · doi:10.1038/onc.2015.287 · Cited by 161
Han, L., Zhang, E.-B., Yin, D.-D., Kong, R., Xu, T.-P., Chen, W.-M., Xia, R., Shu, Y.-Q., & De, W. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.30 · Cited by 161
“The BCL-2 protein family determines the commitment of cells to apoptosis, especially Bcl-2, is upregulated in many types of tumors.(24) In addition, Core promoters of cell apoptosis genes downstream of p53 are distinguished from other p53 target genes by the binding site for the transcription factor NF-YA.”
BackgroundEnhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1
Teh, T.-C., Nguyen, N.-Y., Moujalled, D. M., Segal, D., Pomilio, G., Rijal, S., Jabbour, A., Cummins, K., Lackovic, K., Blombery, P., et al. (2018) · Leukemia · doi:10.1038/leu.2017.243 · Cited by 159
Targeting the Bcl-2 Family in B Cell Lymphoma
Adams, C. M., Clark-Garvey, S., Porcu, P., & Eischen, C. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00636 · Cited by 159
“The mechanism by which the anti-apoptotic Bcl-2 family proteins inhibit apoptosis is predominately governed by their capacity to bind and sequester the pro-apoptotic BH-3-only proteins or Bax and Bak, ultimately preventing mitochondrial membrane permeabilization [Figure 1A, (83)].”
BackgroundPelz, N. F., Bian, Z., Zhao, B., Shaw, S., Tarr, J. C., Belmar, J., Gregg, C., Camper, D. V., Goodwin, C. M., Arnold, A. L., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01660 · Cited by 150
DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
Abbassi, R. H., Johns, T. G., Kassiou, M., & Munoz, L. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.03.004 · Cited by 170
Ribeiro, R. A., Wanderley, C. W. S., Wong, D. V. T., Mota, J. M. S. C., Leite, C. A. V. G., Souza, M. H. L. P., Cunha, F. Q., & Lima-Júnior, R. C. P. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3139-y · Cited by 146
Carrington, E. M., Zhan, Y., Brady, J. L., Zhang, J., Sutherland, R. M., Anstee, N. S., Schenk, R. L., Vikstrom, I. B., Delconte, R. B., Segal, D., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.30 · Cited by 182
Self-citationDadashpour, M., Firouzi‐Amandi, A., Pourhassan‐Moghaddam, M., Maleki, M. J., Soozangar, N., Jeddi, F., Nouri, M., Zarghami, N., & Pilehvar‐Soltanahmadi, Y. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.07.053 · Cited by 157
Zhāng, Q., Xiong, K., Yan, W., Yang, Y., Hu, X., Ning, W.-Y., Liao, L.-S., Lu, S., & Zhao, W. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.331539 · Cited by 172
“…of pyroptosis or apoptosis or necroptosis were detected (Table 1) (Fink and Cookson, 2005; Bergsbaken et al., 2009; Kaczmarek et al., 2013; Nikoletopoulou et al., 2013; Czabotar et al., 2014; Kovacs and Miao, 2017; Hu et al., 2021) and that they should contain at least two or more key proteins.”
BackgroundT cell–derived interferon-γ programs stem cell death in immune-mediated intestinal damage
Takashima, S., Martin, M. L., Jansen, S. A., Fu, Y., Bos, J., Chandra, D., O’Connor, M. H., Mertelsmann, A. M., Vinci, P., Kuttiyara, J., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aay8556 · Cited by 154
Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy
Rapoport, B. L., & Anderson, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040959 · Cited by 164
Should mutant TP53 be targeted for cancer therapy?
Wang, Z., Strasser, A., & Kelly, G. L. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00962-9 · Cited by 184
“BIM, PUMA, NOXA) to initiate apoptosis, and the effectors of apoptosis (BAX, BAK) to kill cells [18, 19].”
BackgroundSelf-citationFerroptosis: a double-edged sword mediating immune tolerance of cancer
Dang, Q., Sun, Z., Wang, Y., Wang, L., Liu, Z., & Han, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05384-6 · Cited by 164
Ali‐Seyed, M., Jantan, I., Vijayaraghavan, K., & Bukhari, S. N. A. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12682 · Cited by 168
Zhang, Y., Zhang, Y. W., Jin, X., Zhou, X.-H., Dong, X.-H., Yu, W., & Gao, W. (2019) · Molecules · doi:10.3390/molecules24091838 · Cited by 156
“Bcl-2 and Bax proteins are key apoptosis regulators [22], and their ratio is an important indicator in determining whether apoptosis occurs or not [23].”
BackgroundPyroptosis in Liver Disease: New Insights into Disease Mechanisms
Wu, J., Lin, S., Wan, B., Velani, B., & Zhu, Y. (2019) · Aging and disease · doi:10.14336/ad.2019.0116 · Cited by 153
“The B-cell lymphoma 2 (Bcl-2) family members and the tumor necrosis factor (TNF) family members are prominent regulators of apoptosis[13, 14].”
BackgroundTargeting Autophagy for Cancer Treatment and Tumor Chemosensitization
Pérez-Hernández, M., Arias, A., Martínez‐García, D., Pérez‐Tomás, R., Quesada, R., & Soto‐Cerrato, V. (2019) · Cancers · doi:10.3390/cancers11101599 · Cited by 165
“In general, BH3 mimetics may stimulate autophagy by liberating Beclin-1 from Bcl2 and Bcl-XL inhibition [85,86].”
BackgroundSaga of Mcl-1: regulation from transcription to degradation
Senichkin, V. V., Streletskaia, A. Y., Gorbunova, A. S., Zhivotovsky, B., & Kopeina, G. S. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0486-3 · Cited by 155
“In brief, the interactions between BH3-binding grooves and BH3-domains underlie the mutual inhibition of the two subsets of Bcl-2 family members [15].”
BackgroundDevelopments of CRBN-based PROTACs as potential therapeutic agents
Wang, C., Zhang, Y., Wu, Y., & Xing, D. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113749 · Cited by 162
Metadata
- Authors
- Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M.
- Affiliations
- The University of Melbourne (AU)
- Corresponding author
- Strasser, Andreas
- Adams, Jerry M.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2013-12-20
- Volume
- 15
- Issue
- 1
- Pages
- 49-63
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2088883749
- Cited by
- 3,219
- References
- 218
- Citations by year
- 2026: 164 · 2025: 220 · 2024: 249 · 2023: 230 · 2022: 265 · 2021: 319 · 2020: 299 · 2019: 285 · 2018: 314 · 2017: 292 · 2016: 287 · 2015: 209 · 2014: 77 · 2013: 1
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2 family proteins, apoptosis, mitochondrial outer membrane, BCL-2 inhibitor, cancer therapy, autoimmune disease, neurodegeneration, ischemia, apoptosis regulation
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Models, Molecular, Molecular Sequence Data, Neoplasms, Signal Transduction, Apoptosis, Protein Structure, Secondary, Proto-Oncogene Proteins c-bcl-2, Apoptosis Regulatory Proteins, Protein Multimerization, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.